September 5, 2022
Masato Matsumoto, Director, National Federation of Health Insurance Societies (Kenporen) Japan's first off-year drug price revision carried out in 2021 covered products with price gaps of “above 5%” between NHI prices and market prices, drawing fire from the pharmaceutical industry...read more